SHARE

THL Partners to acquire clinical trial network Headlands from KKR for $600m

Private equity firm THL Partners will buy a majority stake in U.S. clinical trial network Headlands from KKR for $600m. The acquisition targets steady growth in trial sites as pharma investment rises and AI accelerates drug development.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.